Several lines of evidence indicate that the p53 tumour suppressor protein is critical for the prevention of neoplastic transformation. First, the p53 gene is mutated in more than half of all human cancers (Levine, 1997) . Second, inactivation of p53 by human papillomavirus early protein 6 (HPV-E6) is strongly linked with the development of cervical cancers (Thomas et al., 1999) . Third, germline transmission of non-functional alleles of p53 leads to the development of a plethora of malignancies (Levine, 1997; Malkin, 1994) . The critical antineoplastic eect of p53 is thought to arise through the ability of p53 to regulate growth suppressive processes such as G 1 arrest and apoptosis (Levine, 1997; Vogelstein et al., 2000) . It has been suggested that these characteristics of p53 make wildtype p53 expressing tumours more responsive to therapy (Lowe and Lin, 2000) . This is not necessarily the case because p53 can also regulate cellular processes such as DNA repair that may contribute to the resistance of some tumours to DNA damaging therapies (Ford and Hanawalt, 1997; McKay et al., 1997a McKay et al., ,b, 1999 McKay et al., , 2000 McKay et al., , 2001 Smith et al., 1995; Fornace, 1996, 1997; Wani et al., 1999) . Therefore, it is important to understand how p53 regulates these diverse cellular processes.
UV light and the chemotherapeutic agent cisplatin induce DNA lesions that are eective blocks to RNA polymerase II and thus block transcription (Cullinane et al., 1999; Mello et al., 1995; Selby et al., 1997) . These DNA lesions are removed by the nucleotide excision repair pathway (NER) and this DNA repair pathway can be further subdivided into genetically separable subpathways termed transcription-coupled repair (TCR) and global genomic repair (GGR) . TCR is required for the preferential removal of transcription-blocking lesions from the template strand of active genes whereas GGR is responsible for the removal of DNA lesions from the bulk of the genome . Cell lines derived from individuals aected with the disorders xeroderma pigmentosum (except the variant form) and Cockayne syndrome have defects in one or both of these subpathways of NER. Speci®cally, xeroderma pigmentosum group C cells (XP-C) have a defect in GGR but not TCR of UV-induced DNA damage. In contrast, Cockayne syndrome group A and B cells (CS-A and CS-B) are defective in TCR but not GGR of UV-induced DNA damage (van Hoen et al., 1993) . Other NER defective xeroderma pigmentosum cells have defects in both TCR and GGR (for example XP-A and XP-B cells) . These ®broblast strains provide a model system in which to examine the relationship amongst p53, NER and apoptosis following UV-irradiation.
Using this model system, it has been reported that TCR-de®cient ®broblasts (for example: CS-A, CS-B, XP-A and XP-B) are exquisitely sensitive to UV-and cisplatin-induced apoptosis and this correlates with the induction of p53 (Andera and Wasylyk, 1997; Ljungman and Zhang, 1996; Ljungman et al., 1999; McKay et al., 1998) . Similarly, pharmacological agents that inhibit transcription induce p53 and apoptosis at similar concentrations . These reports suggest that impaired transcription promotes p53-dependent apoptosis in primary human ®broblasts (Andera and Wasylyk, 1997; Ljungman et al., 1999) . However, primary and immortalized ®broblasts lacking functional p53 can be hypersensitive to apoptosis induced by moderate doses of UV light (Lackinger et al., 2001, Lackinger and Kaina, 2000; Wani et al., 1999) . We found that this hypersensitivity correlated with a decrease in the capacity of p53-de®cient cells to recover transcription . Furthermore, we were able to demonstrate that p53 had both pro-apoptotic and anti-apoptotic eects in UV-irradiated colon cancer cells and these alternate fates could be distinguished based on the timing of functional p53 expression (McKay et al., 2000) . Therefore, prior to this study, it was not clear whether the induction of p53 following exposure to low doses of UV light in TCR-de®cient strains (Ljungman and Zhang, 1996; McKay et al., 1998; Yamaizumi and Sugano, 1994) contributed to apoptosis in these cells. To address this issue, we generated normal, XP-A, XP-B, XP-C and CS-B ®broblast strains expressing HPV-E6. These cells made it possible to assess the requirement for p53 in UV and cisplatin-induced apoptosis in cells with defects in TCR (CS-B), GGR (XP-C), both (XP-A and XP-B) or neither.
Expression of HPV-E6 in these cell lines prevented the UV-induced accumulation of p53, as assessed by either Western blot analysis (Figure 1 ) or immunouorescence microscopy (data not shown). As previously reported (Conforti et al., 2000; Ljungman and Zhang, 1996; McKay et al., 1998) , TCR de®cient XP-A, XP-B and CS-B ®broblasts underwent massive apoptosis following exposure to low doses of UV light whereas XP-C and normal cells did not (Figure 2 ). Con®rming previous studies in primary ®broblasts and mammary epithelial cells (El-Mahdy et al., 2000; , HPV-E6 expression in the normal skin ®broblast strains resulted in a modest increase in the induction of apoptosis following exposure to low doses of UV light (Figure 2a) . Strikingly, XP-CE6 cells were as sensitive to UVinduced apoptosis as XP-AE6, XP-BE6 and CS-BE6 cells (compare Figure 2b and c) . Surprisingly, the expression of HPV-E6 did not signi®cantly inhibit the induction of apoptosis in any of the TCR-de®cient cell lines (Figures 2c and 3) . Therefore, the induction of apoptosis in all strains was p53-independent. The increased sensitivity of XP-CE6 cells correlated with a decrease in the capacity of these cells to recover mRNA synthesis following UV-irradiation (Figure 3 , left panel). In fact, the sensitivity of each ®broblast Figure 1 Human papillomavirus 16-E6 blocks the induction of p53 following UV-irradiation in primary human ®broblasts. The LXSN retroviral vector was used to introduce HPV-E6 into primary human ®broblasts (Coriell Repositories). Brie¯y, exponentially growing cells were incubated with 4 ml of retrovirus suspension (LXSN or LXSN-E6) with 4 mg/ml polybrene for 2 h. Fresh medium was replaced and cells were incubated overnight. Selection for neomycin resistance (400 mg/ml of G418, Sigma) was commenced 24 h following infection. All experiments were performed between passage 3 and 10. The level of p53 protein was assessed by Western blot analysis using anti-p53 monoclonal antibody (AB-2, Oncogene Science). An anti-b-actin antibody (AC-74, Sigma) was used to con®rm equal loading of protein samples. Doses of UV light were 20 J/m 2 for normal and XP-C ®broblasts and 10 J/m 2 for XP-A, XP-B and CS-B cells Our results indicate that p53 protects against UV-induced apoptosis in a manner dependent on TCR and the recovery of mRNA synthesis. DNA damage induced by the chemotherapeutic agent cisplatin can be repaired by TCR (May et al., 1993) so TCR may be an important determinant of sensitivity to cisplatin-induced apoptosis. As observed following UV-irradiation, we found that all TCRde®cient ®broblast strains were extremely sensitive to the induction of apoptosis following exposure to 5 mM cisplatin whereas TCR-pro®cient normal or XP-C ®broblasts were not (Figure 4) . The expression of HPV-E6 had very little eect on the sensitivity of TCR-de®cient XP-A, XP-B or CS-B cells (Figure 4c ). In contrast, HPV-E6 expression sensitized TCRpro®cient ®broblasts (XP-C and normal) to cisplatininduced apoptosis (Figure 4a,b) . Most strikingly, XP-CE6 and NF-E6 cells were as sensitive as XP-AE6, XP-BE6 and CS-BE6 cells to cisplatin-induced apoptosis (Figure 4) . These results indicate that p53 protects cells against cisplatin-induced apoptosis in a manner dependent on TCR.
As indicated above, TCR-de®cient ®broblasts (XP-A, XP-B and CS-B cells) were found to be extremely sensitive to UV-and cisplatin-induced apoptosis compared to TCR-pro®cient ®broblasts (XP-C and normal) and this sensitivity was not altered by HPV-E6 expression. This implies that persistent transcription-blocking DNA lesions triggered the induction of p53-independent apoptosis . This was unexpected given the tight correlation between the induction of p53 and apoptosis in these primary human ®bro-blasts (Conforti et al., 2000; Ljungman and Zhang, 1996; McKay et al., 1998) . However, these results support a model in which transcriptional stresses lead to the induction of apoptosis independent of p53 status (Koumenis and Giaccia, 1997; .
Our previous results and those presented here indicate that p53 stimulates the recovery of mRNA synthesis following DNA damage and protects against UV-and cisplatin-induced apoptosis McKay et al., , 2000 McKay et al., , 2001 . This activity of p53 is clearly independent of its role in regulating GGR (Ford and Hanawalt, 1997) because HPV-E6 expression had a dramatic aect on GGR-de®cient XP-C ®broblasts. In fact, our results are consistent with reports suggesting the involvement of p53 in TCR (Barley et al., 1998; McKay et al., 1997a Mirzayans et al., 1996; Therrien et al., 1999; Wang et al., 1995) , however the contribution of p53 to the regulation of this DNA repair pathway remains somewhat controversial . Whereas the role of p53 in regulating GGR has not been challenged, there are con¯icting reports regarding a role for p53 in TCR (Ford and Hanawalt, 1997; Therrien et al., 1999) . There are a number of ways to reconcile our results with these apparent discrepancies. It is possible that the primary role of p53 in TCR is at a step subsequent to the excision of transcription blocking DNA lesions such that p53 only has a modest eect in conventional TCR assays. Alternatively, the defect in the recovery of mRNA synthesis may be the cause not the consequence of a TCR defect. Therefore this DNA repair defect may arise indirectly from a defect in overall transcription following DNA damage.
In summary, although a tight correlation has been reported between the induction of p53 and apoptosis in primary human ®broblasts following exposure to UV light and cisplatin treatment (Andera and Wasylyk, 1997; Ljungman and Zhang, 1996; McKay et al., 1998) , the induction of apoptosis following treatment with these agents was found to be p53-independent. In fact, p53 was found to be protective against the induction of Figure 3 Correlation between the induction of apoptosis and impaired transcription following UV-irradiation. The incorporation of [ 3 H]uridine into the polyadenylated fraction of RNA was assessed 6 h following exposure to 10 J/m 2 UV light (left panel), as previously described (Ljungman and Zhang, 1996) . Under these conditions, UV-induced DNA damage reduces transcription to approximately 60% immediately following UV-irradiation and the recovery of mRNA synthesis occurs within 6 h in transcriptioncoupled repair-pro®cient ®broblasts McKay et al., 2001) . The induction of apoptosis was assessed 72 h following exposure to 10 J/m 2 of UV light (right panel). A striking inverse correlation between the induction of apoptosis (right panel) and post-UV transcription (left panel) was observed apoptosis following exposure to UV light and cisplatin in TCR-pro®cient ®broblasts. These results may have important implications for cancer therapies that involve the induction of transcription-blocking DNA damage.
